Devon Industries, Inc. v. American Medical Manufacturing, Inc.

19 F.3d 39, 1994 U.S. App. LEXIS 12484, 1994 WL 28362
CourtCourt of Appeals for the Federal Circuit
DecidedFebruary 3, 1994
Docket93-1307
StatusUnpublished

This text of 19 F.3d 39 (Devon Industries, Inc. v. American Medical Manufacturing, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Devon Industries, Inc. v. American Medical Manufacturing, Inc., 19 F.3d 39, 1994 U.S. App. LEXIS 12484, 1994 WL 28362 (Fed. Cir. 1994).

Opinion

19 F.3d 39

NOTICE: Federal Circuit Local Rule 47.6(b) states that opinions and orders which are designated as not citable as precedent shall not be employed or cited as precedent. This does not preclude assertion of issues of claim preclusion, issue preclusion, judicial estoppel, law of the case or the like based on a decision of the Court rendered in a nonprecedential opinion or order.
DEVON INDUSTRIES, INC., Plaintiff-Appellee,
v.
AMERICAN MEDICAL MANUFACTURING, INC., Defendant-Appellant.

No. 93-1307.

United States Court of Appeals, Federal Circuit.

Feb. 3, 1994.

Before NIES, Chief Judge, MAYER and LOURIE, Circuit Judges.

DECISION

LOURIE, Circuit Judge.

American Medical Manufacturing, Inc. ("AMMI") appeals from an order of the United States District Court for the Central District of California granting the motion for preliminary injunction of Devon Industries, Inc. enjoining AMMI from infringing claim 10 of U.S. Patent 4,605,124 pending a trial for patent infringement on the merits. Devon Indus., Inc. v. American Medical Mfg., Inc., No. CV 92-7406-RMT (SHx) (C.D.Cal. Feb. 26, 1993) (Order). Because the court's grant of a preliminary injunction was based on an improper claim interpretation, an error of law, we vacate and remand.

DISCUSSION

Dan Sandel, presently Devon's Chief Executive Officer, and Michael Hoftman, formerly Devon's Senior Vice President and presently AMMI's President and Chief Executive Officer, jointly invented the claimed subject matter of the '124 patent, entitled "Disposable Cover for Surgical Light Handle," while both were employed by Devon. The invention relates to operating room light fixtures that are positioned above an operating table and handled by medical personnel during surgical procedures. Generally, the invention includes a replacement light fixture handle, an adapter for connecting the replacement light fixture handle to a light fixture, and a sterile cover for covering the replacement light fixture handle. Using such a cover, medical personnel may grip and reposition a surgical light by its handle, replacing the cover after each use to maintain a sterile environment in the vicinity of a patient. Prior to filing the patent application that issued as the '124 patent, Sandel and Hoftman assigned the invention to Devon.

After leaving Devon, Hoftman designed a replacement light fixture handle, mounting adapter, and disposable cover for AMMI ("the AMMI assembly"), and Hoftman was granted U.S. Patent 5,156,456 for such an assembly. On December 17, 1992, Devon sued AMMI for infringement of claim 101 of the '124 patent, and applied to the district court for a temporary restraining order to prevent the manufacture and sale of AMMI's assembly. The district court denied Devon's application for a temporary restraining order, but invited Devon to file a motion for preliminary injunction, which Devon did. AMMI filed an opposition.

The motion for preliminary injunction and opposition were supported by declarations and exhibits, including photographs of the allegedly infringing AMMI assembly. The trial judge cancelled a scheduled hearing in connection with the motion and notified the parties that he would decide the motion based on the submitted record. Without a hearing and without inspecting the actual AMMI assembly, the judge entered an order enjoining AMMI from infringing claim 10 of the '124 patent. From this order, AMMI appealed. We have exclusive jurisdiction over such an appeal pursuant to 28 U.S.C. Sec. 1292(a)(1) and (c)(1) (1988).

The issuance of a preliminary injunction is a matter within the discretion of the district court. New England Braiding Co., Inc. v. A.W. Chesterton Co., 970 F.2d 878, 882, 23 USPQ2d 1622, 1625 (Fed.Cir.1992). However, to obtain preliminary injunctive relief, a movant must establish a right thereto in light of the following four factors: (1) whether the movant is reasonably likely to succeed on the merits at trial; (2) whether the movant will suffer irreparable harm in the absence of preliminary relief; (3) whether the balance of hardships tips in the movant's favor; and (4) whether the injunction is in the public interest. Id. (citations omitted). Each factor must be weighed and assessed against the others and against the form and magnitude of the relief requested. Hybritech, Inc. v. Abbott Lab., 849 F.2d 1446, 1451, 7 USPQ2d 1191, 1195 (Fed.Cir.1988). A court's grant of a preliminary injunction will be overturned only on a showing that it abused its discretion, committed an error of law, or seriously misjudged the evidence. We-Care, Inc. v. Ultra Mark, Int'l Corp., 930 F.2d 1567, 1570, 18 USPQ2d 1562, 1564 (Fed.Cir.1991) (quoting H.H. Robertson, Co. v. United Steel Deck, Inc., 820 F.2d 384, 387, 2 USPQ2d 1926, 1927 (Fed.Cir.1987)).

The first factor required to be established by a party seeking a preliminary injunction is that there be a reasonable likelihood of success on the merits when the trial court finally adjudicates the dispute. A patent holder must establish a likelihood of success on the merits both with respect to infringement and validity. Hybritech, 849 F.2d at 1451, 7 USPQ2d at 1196. AMMI principally contests the district court's determination that Devon will likely succeed on the merits of its infringement claim at trial.2

A determination of patent infringement requires a two-step analysis. First, a claim must be interpreted to determine its scope and meaning; second, it must be determined whether an accused device is within the scope of the properly interpreted claim. ZMI Corp. v. Cardiac Resuscitator Corp., 844 F.2d 1576, 1578, 6 USPQ2d 1557, 1559 (Fed.Cir.1988). The first step is an issue of law and the second a question of fact. Minnesota Mining & Mfg., Co. v. Johnson & Johnson Orthopaedics, Inc., 976 F.2d 1559, 1570, 24 USPQ2d 1321, 1330 (Fed.Cir.1992) (citations omitted).

AMMI argues that two limitations of claim 10 were misinterpreted by the district court and that, as properly construed, they are not met by the AMMI assembly. The first claim limitations at issue is "[cover] flange being of a generally like configuration to that of said handle flange for mating engagement with said handle flange, whereby said cover body may be fitted over and closely fitted to said replacement light fixture handle." AMMI argues that the cover flange is limited to one that is approximately the same size and shape as the light fixture handle flange. We disagree.

Words in a claim are to be given their ordinary and accustomed meaning unless it appears the inventor used them differently. See, e.g., Envirotech Corp. v. Al George, Inc., 730 F.2d 753

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Autogiro Company of America v. The United States
384 F.2d 391 (Court of Claims, 1967)
Digital Equipment Corporation v. Emulex Corporation
805 F.2d 380 (Federal Circuit, 1986)
Zmi Corporation v. Cardiac Resuscitator Corporation
844 F.2d 1576 (Federal Circuit, 1988)
Hybritech Incorporated v. Abbott Laboratories
849 F.2d 1446 (Federal Circuit, 1988)
Biodex Corporation v. Loredan Biomedical, Inc.
946 F.2d 850 (Federal Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
19 F.3d 39, 1994 U.S. App. LEXIS 12484, 1994 WL 28362, Counsel Stack Legal Research, https://law.counselstack.com/opinion/devon-industries-inc-v-american-medical-manufacturing-inc-cafc-1994.